Faculty profile
Kishor Wasan
Back to facultyThis profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Clozapine alone versus clozapine and risperidone with refractory schizophrenia.
The New England journal of medicine · 2006
Latest funding
- $956,250
Understanding epigenetic regulation and modulation of cell stress responses by the cholesterol transporter, scavenger receptor-B1 as a novel target for treating advanced prostate cancer
CIHR · 2022 · Principal investigator
- $23,598
A global health research collaboration on engagement in HIV care: UBC, AMREF and AKU
CIHR · 2013 · Co-investigator
- $22,500
The Neglected Global Diseases Initiative at UBC: Research Collaboration for the Developing World
CIHR · 2011 · Nominated PI
1 publications.
Clozapine alone versus clozapine and risperidone with refractory schizophrenia.
Honer WG, Thornton AE, Chen EY, Chan RC, Wong JO, Bergmann A, Falkai P, Pomarol-Clotet E, McKenna PJ, Stip E, Williams R, MacEwan GW, Wasan K, Procyshyn R, Clozapine and Risperidone Enhancement (CARE) Study Group
Understanding epigenetic regulation and modulation of cell stress responses by the cholesterol transporter, scavenger receptor-B1 as a novel target for treating advanced prostate cancer
Principal investigators: Cox, Michael E; Wasan, Kishor M
Keywords: Cell Stress Pathways; Cholesterol; Epigenetics; Pharmacologic Inhibitors; Prostate Cancer; Scavenger Receptor-B1; Synthetic Lethal Screen; Therapy Resistance
A global health research collaboration on engagement in HIV care: UBC, AMREF and AKU
Principal investigators: Lester, Richard T
Keywords: Engagement In Care; Global Health; Hiv/Aids; International Collaboration; Research Partnerships; Retention In Care; Sub-Saharan Africa
The Neglected Global Diseases Initiative at UBC: Research Collaboration for the Developing World
Principal investigators: Wasan, Kishor M
Keywords: Leishmaniasis; Malaria; Neglected Global Diseases; Vaccines; Vector Control
Development and potential mechanisms in bifunctional lanthanide compound enhancement of deteriorating bone structures
Principal investigators: Orvig, Chris
The role of serum lipoproteins in optimizing amphotericin B therapy
Principal investigators: Wasan, Kishor M
Keywords: Amphotericin B; Amphotericin B Lipid Complex; Cholesteryl Ester Transfer Protein; Hplc; Infectious Diseases And Co-Infection Issues; Lipoproteins
Development and potential mechanisms in bifunctional lanthanide compound enhancement of deteriorating bone structures
Principal investigators: Orvig, Christopher E
Keywords: Lanthanides
The physiological role of P-glycoprotein in the gastrointestinal absorption of cholesterol
Principal investigators: Lee, Stephen D
Keywords: Animal Models; Cardiovascular System; Cell Culture Models; Cholesterol Absorption; Cholesterol Excretion; Gastrointestinal Physiology; Knockout Studies; Lipid Biochemistry; Lipid Rafts; Lipid Transport
Inhibition of Acyl-Coenzyme A:cholesterol acyltransferase (ACAT) activity will decrease de novo synthesis of androgens within hormone-refractory prostate cancer cells (C4-2).
Principal investigators: Twiddy, Alexis
Keywords: Acat; Androgen Biosynthesis; Androgen Receptor; C4-2 Cells; Cell Culture; Cholesterol; Hormone-Refractory Prostate Cancer; Lncap Cells
Role of Lipids and Lipoproteins in Modifying the Biological Activity of Hydrophobic Drugs
Principal investigators: Wasan, Kishor M
Keywords: Amphotericin B; Fungal Infections; High Pressure Liquid Chromatography; Lipid And Lipoprotein Metabolism; Lipid-Based Drug Delivery; Lymphatic Drug Transport; Pharmacokinetics; Ultracentrifugation
Development of a Novel Oral Amphotericin B Formulation for the Treatment of Systemic Fungal Infections
Principal investigators: Wasan, Kishor M; Bartlett, Karen H; Thornton, Sheila J; Wasan, Ellen K
Keywords: Amphotericin B; Antifungal Animal Models; Co-Infection With Hiv/Aids; Oral Formulation; Systemic Fungal Infections
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.